17β-Estradiol attenuates hypoxic pulmonary hypertension via estrogen receptor-mediated effects.

PubWeight™: 1.95‹?› | Rank: Top 2%

🔗 View Article (PMC 3359941)

Published in Am J Respir Crit Care Med on March 01, 2012

Authors

Tim Lahm1, Marjorie Albrecht, Amanda J Fisher, Mona Selej, Neel G Patel, Jordan A Brown, Matthew J Justice, M Beth Brown, Mary Van Demark, Kevin M Trulock, Dino Dieudonne, Jagadeshwar G Reddy, Robert G Presson, Irina Petrache

Author Affiliations

1: Division of Pulmonary, Allergy, Critical Care and Occupational Medicine, Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana, USA. tlahm@iupui.edu

Articles citing this

Molecular pathogenesis of pulmonary arterial hypertension. J Clin Invest (2012) 2.59

Sex affects bone morphogenetic protein type II receptor signaling in pulmonary artery smooth muscle cells. Am J Respir Crit Care Med (2015) 1.60

Neonatal iron deficiency causes abnormal phosphate metabolism by elevating FGF23 in normal and ADHR mice. J Bone Miner Res (2014) 1.05

Gender, sex hormones and pulmonary hypertension. Pulm Circ (2013) 1.02

Estradiol improves right ventricular function in rats with severe angioproliferative pulmonary hypertension: effects of endogenous and exogenous sex hormones. Am J Physiol Lung Cell Mol Physiol (2015) 1.02

Sex-dependent influence of endogenous estrogen in pulmonary hypertension. Am J Respir Crit Care Med (2014) 1.02

Statement on pregnancy in pulmonary hypertension from the Pulmonary Vascular Research Institute. Pulm Circ (2015) 1.01

Pulmonary arterial hypertension: basis of sex differences in incidence and treatment response. Br J Pharmacol (2014) 0.97

Direct and indirect protection of right ventricular function by estrogen in an experimental model of pulmonary arterial hypertension. Am J Physiol Heart Circ Physiol (2014) 0.96

Dexfenfluramine and the oestrogen-metabolizing enzyme CYP1B1 in the development of pulmonary arterial hypertension. Cardiovasc Res (2013) 0.90

Higher Estradiol and Lower Dehydroepiandrosterone-Sulfate Levels Are Associated with Pulmonary Arterial Hypertension in Men. Am J Respir Crit Care Med (2016) 0.87

Estrogen paradox in pulmonary hypertension: current controversies and future perspectives. Am J Respir Crit Care Med (2012) 0.86

Oestrogen receptor alpha in pulmonary hypertension. Cardiovasc Res (2015) 0.85

Neonatal hyperoxic lung injury favorably alters adult right ventricular remodeling response to chronic hypoxia exposure. Am J Physiol Lung Cell Mol Physiol (2015) 0.84

In vivo knockdown of intersectin-1s alters endothelial cell phenotype and causes microvascular remodeling in the mouse lungs. Apoptosis (2013) 0.84

A Sex-Specific MicroRNA-96/5-Hydroxytryptamine 1B Axis Influences Development of Pulmonary Hypertension. Am J Respir Crit Care Med (2015) 0.83

LC3 as a potential therapeutic target in hypoxia-induced pulmonary hypertension. Autophagy (2012) 0.82

17β-Estradiol Attenuates Conduit Pulmonary Artery Mechanical Property Changes With Pulmonary Arterial Hypertension. Hypertension (2015) 0.82

17β-Estradiol mediates superior adaptation of right ventricular function to acute strenuous exercise in female rats with severe pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol (2016) 0.81

The right ventricle and pulmonary hypertension. Heart Fail Rev (2016) 0.80

Estrogen administered after cardiac arrest and cardiopulmonary resuscitation ameliorates acute kidney injury in a sex- and age-specific manner. Crit Care (2015) 0.80

Endogenous estrogen attenuates hypoxia-induced pulmonary hypertension by inhibiting pulmonary arterial vasoconstriction and pulmonary arterial smooth muscle cells proliferation. Int J Med Sci (2013) 0.79

Estrogen receptor ERα plays a major role in ethanol-evoked myocardial oxidative stress and dysfunction in conscious female rats. Alcohol (2015) 0.78

Nicotinamide Adenine Dinucleotide Phosphate Oxidase-Mediated Redox Signaling and Vascular Remodeling by 16α-Hydroxyestrone in Human Pulmonary Artery Cells: Implications in Pulmonary Arterial Hypertension. Hypertension (2016) 0.78

The serotonin transporter promotes a pathological estrogen metabolic pathway in pulmonary hypertension via cytochrome P450 1B1. Pulm Circ (2016) 0.78

Sex differences in the pulmonary circulation: implications for pulmonary hypertension. Am J Physiol Heart Circ Physiol (2014) 0.77

Oestrogen inhibition reverses pulmonary arterial hypertension and associated metabolic defects. Eur Respir J (2017) 0.77

Estrogen receptor-dependent attenuation of hypoxia-induced changes in the lung genome of pulmonary hypertension rats. Pulm Circ (2017) 0.77

Selective endothelin-A receptor blockade attenuates endotoxin-induced pulmonary hypertension and pulmonary vascular dysfunction. Pulm Circ (2014) 0.76

Estrogen maintains mitochondrial content and function in the right ventricle of rats with pulmonary hypertension. Physiol Rep (2017) 0.75

Severe pulmonary hypertension in aging female apolipoprotein E-deficient mice is rescued by estrogen replacement therapy. Biol Sex Differ (2017) 0.75

Emerging concepts in smooth muscle contributions to airway structure and function: implications for health and disease. Am J Physiol Lung Cell Mol Physiol (2016) 0.75

Estrogen Preserves Pulsatile Pulmonary Arterial Hemodynamics in Pulmonary Arterial Hypertension. Ann Biomed Eng (2016) 0.75

Novel signaling pathways in pulmonary arterial hypertension (2015 Grover Conference Series). Pulm Circ (2016) 0.75

Hypoxia-Inducible Factor-1α Regulates CD55 in Airway Epithelium. Am J Respir Cell Mol Biol (2016) 0.75

Isolated heart model demonstrates evidence of contractile and diastolic dysfunction in right ventricles from rats with sugen/hypoxia-induced pulmonary hypertension. Physiol Rep (2017) 0.75

Inhibiting oestrogen signalling in pulmonary arterial hypertension: sex, drugs and research. Eur Respir J (2017) 0.75

Articles cited by this

Autophagy in the pathogenesis of disease. Cell (2008) 34.68

Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol (2009) 12.05

Survival in patients with idiopathic, familial, and anorexigen-associated pulmonary arterial hypertension in the modern management era. Circulation (2010) 5.87

Estrogen receptors: how do they signal and what are their targets. Physiol Rev (2007) 5.27

Hypoxia-induced pulmonary vascular remodeling: cellular and molecular mechanisms. Circ Res (2006) 5.00

Interaction of oestrogen receptor with the regulatory subunit of phosphatidylinositol-3-OH kinase. Nature (2000) 4.92

Predicting survival in pulmonary arterial hypertension: insights from the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL). Circulation (2010) 4.66

Sildenafil for treatment of lung fibrosis and pulmonary hypertension: a randomised controlled trial. Lancet (2002) 4.63

Phenol red in tissue culture media is a weak estrogen: implications concerning the study of estrogen-responsive cells in culture. Proc Natl Acad Sci U S A (1986) 4.51

Molecular and cellular basis of cardiovascular gender differences. Science (2005) 4.37

Pulmonary arterial hypertension: baseline characteristics from the REVEAL Registry. Chest (2009) 4.08

A randomised, controlled trial of bosentan in severe COPD. Eur Respir J (2008) 4.06

Estrogen action via the G protein-coupled receptor, GPR30: stimulation of adenylyl cyclase and cAMP-mediated attenuation of the epidermal growth factor receptor-to-MAPK signaling axis. Mol Endocrinol (2002) 3.65

Animal models of pulmonary arterial hypertension: the hope for etiological discovery and pharmacological cure. Am J Physiol Lung Cell Mol Physiol (2009) 3.64

Right ventricular function in cardiovascular disease, part II: pathophysiology, clinical importance, and management of right ventricular failure. Circulation (2008) 3.25

Survival in incident and prevalent cohorts of patients with pulmonary arterial hypertension. Eur Respir J (2010) 2.90

Estrogen receptor alpha mediates the nongenomic activation of endothelial nitric oxide synthase by estrogen. J Clin Invest (1999) 2.71

Hemodynamic and gas exchange effects of sildenafil in patients with chronic obstructive pulmonary disease and pulmonary hypertension. Am J Respir Crit Care Med (2009) 2.70

Association between estrogen receptor alpha gene variation and cardiovascular disease. JAMA (2003) 2.10

Estrogen receptor-alpha mediates the protective effects of estrogen against vascular injury. Circ Res (2002) 2.05

Genomewide RNA expression profiling in lung identifies distinct signatures in idiopathic pulmonary arterial hypertension and secondary pulmonary hypertension. Am J Physiol Heart Circ Physiol (2010) 2.03

Autophagic protein LC3B confers resistance against hypoxia-induced pulmonary hypertension. Am J Respir Crit Care Med (2010) 1.93

Severe pulmonary hypertension and chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2005) 1.91

Estrogen rescues preexisting severe pulmonary hypertension in rats. Am J Respir Crit Care Med (2011) 1.91

Pulmonary vascular remodeling correlates with lung eggs and cytokines in murine schistosomiasis. Am J Respir Crit Care Med (2009) 1.78

Diagnosis, assessment, and treatment of non-pulmonary arterial hypertension pulmonary hypertension. J Am Coll Cardiol (2009) 1.78

ERbeta has nongenomic action in caveolae. Mol Endocrinol (2002) 1.73

Alterations in oestrogen metabolism: implications for higher penetrance of familial pulmonary arterial hypertension in females. Eur Respir J (2009) 1.68

PHYSIOLOGIC STUDIES OF PULMONARY EDEMA AT HIGH ALTITUDE. Circulation (1964) 1.57

Sex hormones are associated with right ventricular structure and function: The MESA-right ventricle study. Am J Respir Crit Care Med (2010) 1.57

Estrogen receptor-beta activation results in S-nitrosylation of proteins involved in cardioprotection. Circulation (2009) 1.56

Estrogen receptor-alpha mediates acute myocardial protection in females. Am J Physiol Heart Circ Physiol (2006) 1.55

Age and sex influence on pulmonary hypertension of chronic hypoxia and on recovery. Am J Physiol (1981) 1.51

Opposite effects of training in rats with stable and progressive pulmonary hypertension. Circulation (2009) 1.51

The effects of hypoxia on the cells of the pulmonary vasculature. Eur Respir J (2007) 1.45

Hemodynamic predictors of survival in scleroderma-related pulmonary arterial hypertension. Am J Respir Crit Care Med (2010) 1.44

Female sex and estrogen receptor-beta attenuate cardiac remodeling and apoptosis in pressure overload. Am J Physiol Regul Integr Comp Physiol (2010) 1.32

Estradiol alters nitric oxide production in the mouse aorta through the alpha-, but not beta-, estrogen receptor. Circ Res (2002) 1.29

Determinants of right ventricular ejection fraction in pulmonary arterial hypertension. Chest (2008) 1.27

Estrogen receptor beta mediates increased activation of PI3K/Akt signaling and improved myocardial function in female hearts following acute ischemia. Am J Physiol Regul Integr Comp Physiol (2009) 1.23

Endogenous estrogen attenuates pulmonary artery vasoreactivity and acute hypoxic pulmonary vasoconstriction: the effects of sex and menstrual cycle. Am J Physiol Endocrinol Metab (2007) 1.19

A new approach to measuring estrogen exposure and metabolism in epidemiologic studies. J Steroid Biochem Mol Biol (2010) 1.19

2-Methoxyestradiol mediates the protective effects of estradiol in monocrotaline-induced pulmonary hypertension. Vascul Pharmacol (2006) 1.17

The serotonin transporter, gender, and 17β oestradiol in the development of pulmonary arterial hypertension. Cardiovasc Res (2010) 1.15

Cyclin-dependent kinase inhibitor p27Kip1, but not p21WAF1/Cip1, is required for inhibition of hypoxia-induced pulmonary hypertension and remodeling by heparin in mice. Circ Res (2005) 1.15

Estradiol-induced attenuation of pulmonary hypertension is not associated with altered eNOS expression. Am J Physiol Lung Cell Mol Physiol (2001) 1.13

Receptors for androgen-binding proteins: internalization and intracellular signalling. J Steroid Biochem Mol Biol (1995) 1.12

Estradiol attenuates hypoxia-induced pulmonary endothelin-1 gene expression. Am J Physiol Lung Cell Mol Physiol (2002) 1.10

Heart and lung VEGF mRNA expression in rats with monocrotaline- or hypoxia-induced pulmonary hypertension. Am J Physiol (1998) 1.10

Strategic plan for lung vascular research: An NHLBI-ORDR Workshop Report. Am J Respir Crit Care Med (2010) 1.09

Hypoxia induces different genes in the lungs of rats compared with mice. Physiol Genomics (2003) 1.07

Effective dosing regimen of 1-aminobenzotriazole for inhibition of antipyrine clearance in rats, dogs, and monkeys. Drug Metab Dispos (2002) 1.05

Selective estrogen receptor-alpha and estrogen receptor-beta agonists rapidly decrease pulmonary artery vasoconstriction by a nitric oxide-dependent mechanism. Am J Physiol Regul Integr Comp Physiol (2008) 1.04

Estrogen loss upregulates hematopoiesis in the mouse: a mediating role of IL-6. Exp Hematol (1995) 1.02

Estrogen-receptor-mediated protection of cerebral endothelial cell viability and mitochondrial function after ischemic insult in vitro. J Cereb Blood Flow Metab (2009) 1.01

Association of estrogen receptor beta gene polymorphisms with left ventricular mass and wall thickness in women. Am J Hypertens (2005) 1.00

Cardiopulmonary responses of male and female swine to simulated high altitude. J Appl Physiol (1973) 1.00

Beta-estradiol attenuates hypoxic pulmonary hypertension by stabilizing the expression of p27kip1 in rats. Respir Res (2010) 1.00

Estrogen receptor alpha gene variation and the risk of stroke. Stroke (2005) 0.99

Estradiol metabolites attenuate monocrotaline-induced pulmonary hypertension in rats. J Cardiovasc Pharmacol (2005) 0.99

The role of menopause in the development of chronic mountain sickness. Am J Physiol (1997) 0.98

The effects of estrogen on pulmonary artery vasoreactivity and hypoxic pulmonary vasoconstriction: potential new clinical implications for an old hormone. Crit Care Med (2008) 0.98

Endothelial estrogen receptor-alpha plays a crucial role in the atheroprotective action of 17beta-estradiol in low-density lipoprotein receptor-deficient mice. Circulation (2009) 0.98

Serotonin transporter, sex, and hypoxia: microarray analysis in the pulmonary arteries of mice identifies genes with relevance to human PAH. Physiol Genomics (2011) 0.97

Mechanism of estrogen-mediated attenuation of hepatic injury following trauma-hemorrhage: Akt-dependent HO-1 up-regulation. J Leukoc Biol (2007) 0.97

Differences in the K(+)-channels opened by cromakalim, acetylcholine and substance P in rat aorta and porcine coronary artery. Br J Pharmacol (1991) 0.95

Tamoxifen and ICI 182,780 negatively influenced cardiac cell growth via an estrogen receptor-independent mechanism. Cardiovasc Res (2003) 0.91

G-protein-coupled receptor 30 mediates estrogen's nongenomic effects after hemorrhagic shock and trauma. Am J Pathol (2007) 0.90

Pregnancy blunts pulmonary vascular reactivity in dogs. Am J Physiol (1980) 0.89

Methoxyestradiols mediate the antimitogenic effects of locally applied estradiol on cardiac fibroblast growth. Hypertension (2002) 0.87

Cardio-respiratory studies in chronic mountain sickness (Monge's syndrome). Respiration (1971) 0.86

17-beta estradiol attenuates hypoxic induction of HIF-1alpha and erythropoietin in Hep3B cells. J Cardiovasc Pharmacol (2004) 0.86

Acute haemodynamic effects of cromakalim in patients with angina pectoris. Br J Clin Pharmacol (1990) 0.83

Pulmonary vascular reactivity is blunted in pregnant rats. J Appl Physiol Respir Environ Exerc Physiol (1982) 0.82

Role of sex hormones in development of chronic mountain sickness in rats. J Appl Physiol (1985) (1994) 0.82

Mice lacking the Raf-1 kinase inhibitor protein exhibit exaggerated hypoxia-induced pulmonary hypertension. Br J Pharmacol (2011) 0.80

Pulmonary hypertension in women. Expert Rev Cardiovasc Ther (2010) 0.79

Catechol-O-methyltransferase inhibition increases the uptake of 11C-3-(3,4-dihydroxyphenyl)-L-alanine in the rat pancreas. Scand J Gastroenterol (1996) 0.77

Articles by these authors

Genetic ablation of Nrf2 enhances susceptibility to cigarette smoke-induced emphysema in mice. J Clin Invest (2004) 6.32

Pathogenesis of chronic obstructive pulmonary disease. J Clin Invest (2012) 1.85

Apoptosis and emphysema: the missing link. Am J Respir Cell Mol Biol (2003) 1.82

A comparison of single-dose caudal clonidine, morphine, or hydromorphone combined with ropivacaine in pediatric patients undergoing ureteral reimplantation. Anesth Analg (2007) 1.77

State of the art. Cellular and molecular mechanisms of alveolar destruction in emphysema: an evolutionary perspective. Proc Am Thorac Soc (2006) 1.75

Rtp801, a suppressor of mTOR signaling, is an essential mediator of cigarette smoke-induced pulmonary injury and emphysema. Nat Med (2010) 1.67

Targeted induction of lung endothelial cell apoptosis causes emphysema-like changes in the mouse. J Biol Chem (2008) 1.44

Anti-type V collagen humoral immunity in lung transplant primary graft dysfunction. J Immunol (2008) 1.42

Adipose stem cell treatment in mice attenuates lung and systemic injury induced by cigarette smoking. Am J Respir Crit Care Med (2010) 1.42

Role of lung maintenance program in the heterogeneity of lung destruction in emphysema. Proc Am Thorac Soc (2006) 1.31

Tissue transglutaminase protects epithelial ovarian cancer cells from cisplatin-induced apoptosis by promoting cell survival signaling. Carcinogenesis (2008) 1.24

Mechanisms of lung endothelial barrier disruption induced by cigarette smoke: role of oxidative stress and ceramides. Am J Physiol Lung Cell Mol Physiol (2011) 1.21

Stat3 downstream genes serve as biomarkers in human lung carcinomas and chronic obstructive pulmonary disease. Lung Cancer (2008) 1.17

Apoptotic sphingolipid signaling by ceramides in lung endothelial cells. Am J Respir Cell Mol Biol (2008) 1.11

Lung endothelial monocyte-activating protein 2 is a mediator of cigarette smoke-induced emphysema in mice. J Clin Invest (2011) 1.10

Two-photon imaging within the murine thorax without respiratory and cardiac motion artifact. Am J Pathol (2011) 1.09

Stimulation of sphingosine 1-phosphate signaling as an alveolar cell survival strategy in emphysema. Am J Respir Crit Care Med (2009) 1.08

Spinal ceramide modulates the development of morphine antinociceptive tolerance via peroxynitrite-mediated nitroxidative stress and neuroimmune activation. J Pharmacol Exp Ther (2008) 1.07

Type V collagen-induced oral tolerance plus low-dose cyclosporine prevents rejection of MHC class I and II incompatible lung allografts. J Immunol (2009) 1.05

Neonatal iron deficiency causes abnormal phosphate metabolism by elevating FGF23 in normal and ADHR mice. J Bone Miner Res (2014) 1.05

Sphingolipid-mediated inhibition of apoptotic cell clearance by alveolar macrophages. J Biol Chem (2010) 1.04

Dihydroceramide-based response to hypoxia. J Biol Chem (2011) 1.02

Pulmonary ischemia induces lung remodeling and angiogenesis. J Appl Physiol (1985) (2005) 1.00

Cigarette smoke exposure inhibits contact hypersensitivity via the generation of platelet-activating factor agonists. J Immunol (2013) 0.98

α₁-Antitrypsin modulates lung endothelial cell inflammatory responses to TNF-α. Am J Respir Cell Mol Biol (2013) 0.98

Ceramide synthases expression and role of ceramide synthase-2 in the lung: insight from human lung cells and mouse models. PLoS One (2013) 0.97

Plasma sphingolipids associated with chronic obstructive pulmonary disease phenotypes. Am J Respir Crit Care Med (2015) 0.95

Lung disease associated with alpha1-antitrypsin deficiency. Proc Am Thorac Soc (2010) 0.94

Periostin regulates goblet cell metaplasia in a model of allergic airway inflammation. J Immunol (2011) 0.93

Lung transplant ischemia reperfusion injury: metalloprotease inhibition down-regulates exposure of type V collagen, growth-related oncogene-induced neutrophil chemotaxis, and tumor necrosis factor-alpha expression. Transplantation (2008) 0.92

Type V collagen induced tolerance suppresses collagen deposition, TGF-β and associated transcripts in pulmonary fibrosis. PLoS One (2013) 0.91

CFTR regulation of intracellular pH and ceramides is required for lung endothelial cell apoptosis. Am J Respir Cell Mol Biol (2009) 0.91

MSPrep--summarization, normalization and diagnostics for processing of mass spectrometry-based metabolomic data. Bioinformatics (2013) 0.90

Cavopulmonary assist in the neonate: an alternative strategy for single-ventricle palliation. J Thorac Cardiovasc Surg (2004) 0.89

Phase separation in binary mixtures of bipolar and monopolar lipid dispersions revealed by 2H NMR spectroscopy, small angle x-ray scattering, and molecular theory. Biophys J (2009) 0.88

Spinal ceramide and neuronal apoptosis in morphine antinociceptive tolerance. Neurosci Lett (2009) 0.88

The development and maintenance of paclitaxel-induced neuropathic pain require activation of the sphingosine 1-phosphate receptor subtype 1. J Biol Chem (2014) 0.87

Neonatal cavopulmonary assist: pulsatile versus steady-flow pulmonary perfusion. Ann Thorac Surg (2006) 0.86

Twenty-four hour cardiopulmonary stability in a model of assisted newborn Fontan circulation. Ann Thorac Surg (2006) 0.85

Mechanism of alpha-1 antitrypsin endocytosis by lung endothelium. FASEB J (2009) 0.85

RTP801 is required for ceramide-induced cell-specific death in the murine lung. Am J Respir Cell Mol Biol (2012) 0.85

From bench to bedside: preclinical evaluation of a self-inactivating gammaretroviral vector for the gene therapy of X-linked chronic granulomatous disease. Hum Gene Ther Clin Dev (2013) 0.84

Cigarette smoke-induced CXCR3 receptor up-regulation mediates endothelial apoptosis. Am J Respir Cell Mol Biol (2012) 0.84

In vivo knockdown of intersectin-1s alters endothelial cell phenotype and causes microvascular remodeling in the mouse lungs. Apoptosis (2013) 0.84

Smoking exposure induces human lung endothelial cell adaptation to apoptotic stress. Am J Respir Cell Mol Biol (2014) 0.84

Regulation of Yorkie activity in Drosophila imaginal discs by the Hedgehog receptor gene patched. Mech Dev (2012) 0.83

Molecular multitasking in the airspace: alpha1-antitrypsin takes on thrombin and plasmin. Am J Respir Cell Mol Biol (2007) 0.83

Effect of cigarette smoke exposure and structural modifications on the α-1 Antitrypsin interaction with caspases. Mol Med (2012) 0.83

LC3 as a potential therapeutic target in hypoxia-induced pulmonary hypertension. Autophagy (2012) 0.82

A monoclonal rat anti-mouse EMAP II antibody that functionally neutralizes pro- and mature-EMAP II in vitro. J Immunol Methods (2009) 0.81

Solid-state ²H NMR shows equivalence of dehydration and osmotic pressures in lipid membrane deformation. Biophys J (2011) 0.80

Heterogeneous capillary recruitment among adjoining alveoli. J Appl Physiol (1985) (2003) 0.79

Blood flow switching among pulmonary capillaries is decreased during high hematocrit. J Appl Physiol (1985) (2004) 0.79

Allergic airway disease in mice alters T and B cell responses during an acute respiratory poxvirus infection. PLoS One (2013) 0.79

HIV envelope protein gp120-induced apoptosis in lung microvascular endothelial cells by concerted upregulation of EMAP II and its receptor, CXCR3. Am J Physiol Lung Cell Mol Physiol (2013) 0.78

Type V collagen-induced tolerance prevents airway hyperresponsiveness. Am J Respir Crit Care Med (2013) 0.76

Human adipose-derived stem cells ameliorate cigarette smoke-induced murine myelosuppression via secretion of TSG-6. Stem Cells (2015) 0.75

Health Disparities in Patients with Pulmonary Arterial Hypertension: A Blueprint for Action. An Official American Thoracic Society Statement. Am J Respir Crit Care Med (2017) 0.75

Pulmonary Retention of Adipose Stromal Cells Following Intravenous Delivery Is Markedly Altered in the Presence of ARDS. Cell Transplant (2015) 0.75

Predictors of recurrent esophageal food impaction: a case-control study. J Clin Gastroenterol (2008) 0.75

Investigation of a catalyst ink dispersion using both ultra-small-angle X-ray scattering and cryogenic TEM. Langmuir (2010) 0.75

An Official American Thoracic Society Workshop Report: Obesity and Metabolism. An Emerging Frontier in Lung Health and Disease. Ann Am Thorac Soc (2017) 0.75

High Intensity Interval Training is Superior to Continuous Training in a Pulmonary Hypertension Rat Model: 751 Board #67 June 1, 3: 30 PM - 5: 00 PM. Med Sci Sports Exerc (2016) 0.75